(March 3, 2016, 3:30 PM EST) -- WASHINGTON, D.C. — An appellate court correctly rejected a pharmaceutical company’s challenge to the way the U.S. Patent and Trademark Office (PTO) calculated patent-term adjustments for two of its patents on treating dead tissue, saying the agency’s decision wasn’t unreasonable, Michelle K. Lee, director of the PTO, responds in a Feb. 18 opposition to a petition with the U.S. Supreme Court (Daiichi Sankyo Company, Ltd. v. Michelle K. Lee, Director, U.S. Patent and Trademark Office, No. 15-652, U.S. Sup.)....